Chronic Disease Management Market Research Report - Forecast till 2027

Chronic Disease Management Market Research Report: By Solution (Educational Solution, Implementation Solution, Consulting Solution and others), Delivery Mode (Cloud-Based, On-Premises and Web-Based), Application (Arthritis, Cardiovascular Disease, Cancer, Diabetes and others), End-User (Providers, Payers) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast till 2027

ID: MRFR/HS/0475-HCR | February, 2021 | Region : Global

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

 

6. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION

6.1. Overview

6.2. Educational Solution

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3. Implementation Solution

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4. Consulting Solution

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5. Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY DELIVERY MODE

7.1. Overview

7.2. Cloud-Based

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3. On-Premises

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4. Web Based

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY APPLICATION

8.1. Overview

8.2. Arthritis

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3. Cardiovascular Disease

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4. Cancer

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.5. Diabetes

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.6. Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY END-USER

9.1. Overview

9.2. Providers

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.3. Payers

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

10. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY REGION

10.1. Overview

10.2. Americas

10.2.1. North America

10.2.1.1. US

10.2.1.2. Canada

10.2.2. Latin America

10.3. Europe

10.3.1. Western Europe

10.3.1.1. Germany

10.3.1.2. France

10.3.1.3. Italy

10.3.1.4. Spain

10.3.1.5. UK

10.3.1.6. Rest of Western Europe

10.3.2. Eastern Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Middle East & Africa

10.5.1. Middle East

10.5.2. Africa

11. COMPANY LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market Share Analysis

11.4. Major Growth Strategy in the Global Chronic Disease Management Market

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of Number of Developments in the Global Chronic Disease Management Market

11.7. Key developments and Growth Strategies

11.7.1. DELIVERY MODE Launch/ Deployment

11.7.2. Mergers and Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix & Market Ratio

11.8.1. Sales & Operating Income 2020

11.8.2. Major Players R&D Expenditure 2020

11.9. Major Players Capital Market Ratio

12. COMPANY PROFILES

12.1. TriZetto Corporation

12.1.1. Company Overview

12.1.2. Product Overview

12.1.3. Financial Overview

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Infosys Limited

12.2.1. Company Overview

12.2.2. Product Overview

12.2.3. Financial Overview

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. Pegasystems Inc.

12.3.1. Company Overview

12.3.2. Product Overview

12.3.3. Financial Overview

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. Siemens Healthcare Private Limited

12.4.1. Company Overview

12.4.2. Product Overview

12.4.3. Financial Overview

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. MINES & Associates, Inc.

12.5.1. Company Overview

12.5.2. Product Overview

12.5.3. Financial Overview

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. Allscripts Healthcare Solutions, Inc.

12.6.1. Company Overview

12.6.2. Product Overview

12.6.3. Financial Overview

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. Koninklijke Philips NV

12.7.1. Company Overview

12.7.2. Product Overview

12.7.3. Financial Overview

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

12.8. EXL Healthcare

12.8.1. Company Overview

12.8.2. Product Overview

12.8.3. Financial Overview

12.8.4. Key Developments

12.8.5. SWOT Analysis

12.8.6. Key Strategies

12.9. Harmony Information Systems, Inc.

12.9.1. Company Overview

12.9.2. Product Overview

12.9.3. Financial Overview

12.9.4. Key Developments

12.9.5. SWOT Analysis

12.9.6. Key Strategies

12.10. ScienceSoft USA Corporation. (US)

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SYNOPSIS, 2020–2027

TABLE 2 GLOBAL CHRONIC DISEASE MANAGEMENT MARKET ESTIMATES & FORECAST, 2020–2027 (USD MILLION)

TABLE 3 GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION, 2020–2027 (USD MILLION)

TABLE 4 GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)

TABLE 5 GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 6 GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 7 GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 8 NORTH AMERICA: CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION, 2020–2027 (USD MILLION)

TABLE 9 NORTH AMERICA: CHRONIC DISEASE MANAGEMENT MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)

TABLE 10 NORTH AMERICA: CHRONIC DISEASE MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 11 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 12 US: CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION, 2020–2027 (USD MILLION)

TABLE 13 US: CHRONIC DISEASE MANAGEMENT MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)

TABLE 14 US: CHRONIC DISEASE MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 15 US: CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 16 CANADA: CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION, 2020–2027 (USD MILLION)

TABLE 17 CANADA: CHRONIC DISEASE MANAGEMENT MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)

TABLE 18 CANADA: CHRONIC DISEASE MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 19 CANADA: CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 20 LATIN AMERICA: CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION, 2020–2027 (USD MILLION)

TABLE 21 LATIN AMERICA: CHRONIC DISEASE MANAGEMENT MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)

TABLE 22 LATIN AMERICA: CHRONIC DISEASE MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 23 LATIN AMERICA: CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 24 EUROPE: CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION, 2020–2027 (USD MILLION)

TABLE 25 EUROPE: CHRONIC DISEASE MANAGEMENT MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)

TABLE 26 EUROPE: CHRONIC DISEASE MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 27 EUROPE: CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 28 WESTERN EUROPE: CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION, 2020–2027 (USD MILLION)

TABLE 29 WESTERN EUROPE: CHRONIC DISEASE MANAGEMENT MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)

TABLE 30 WESTERN EUROPE: CHRONIC DISEASE MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 31 WESTERN EUROPE: CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 32 EASTERN EUROPE: CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION, 2020–2027 (USD MILLION)

TABLE 33 EASTERN EUROPE: CHRONIC DISEASE MANAGEMENT MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)

TABLE 34 EASTERN EUROPE: CHRONIC DISEASE MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 35 EASTERN EUROPE: CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 36 ASIA-PACIFIC: CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION, 2020–2027 (USD MILLION)

TABLE 37 ASIA-PACIFIC: CHRONIC DISEASE MANAGEMENT MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)

TABLE 38 ASIA-PACIFIC: CHRONIC DISEASE MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 39 ASIA-PACIFIC: CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA: CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION, 2020–2027 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA: CHRONIC DISEASE MANAGEMENT MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA: CHRONIC DISEASE MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA: CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)  

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL CHRONIC DISEASE MANAGEMENT MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL CHRONIC DISEASE MANAGEMENT MARKET

FIGURE 4 GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY SOLUTION, 2020 (%)

FIGURE 5 GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY DELIVERY MODE, 2020 (%)

FIGURE 6 GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY APPLICATION, 2020 (%)

FIGURE 7 GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY END USER, 2020 (%)

FIGURE 8 GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY REGION, 2020 (%)

FIGURE 9 AMERICAS: CHRONIC DISEASE MANAGEMENT MARKET SHARE BY REGION, 2020 (%)

FIGURE 10 NORTH AMERICA: CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 11 EUROPE: CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY REGION, 2020 (%)

FIGURE 12 WESTERN EUROPE: CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 ASIA-PACIFIC: CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 14 MIDDLE EAST & AFRICA: CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 15 GLOBAL CHRONIC DISEASE MANAGEMENT MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 16 TRIZETTO CORPORATION: KEY FINANCIALS

FIGURE 17 TRIZETTO CORPORATION: SEGMENTAL REVENUE

FIGURE 18 TRIZETTO CORPORATION: REGIONAL REVENUE

FIGURE 19 INFOSYS LIMITED: KEY FINANCIALS

FIGURE 20 INFOSYS LIMITED: SEGMENTAL REVENUE

FIGURE 21 INFOSYS LIMITED: REGIONAL REVENUE

FIGURE 22 PEGASYSTEMS INC.: KEY FINANCIALS

FIGURE 23 PEGASYSTEMS INC.: SEGMENTAL REVENUE

FIGURE 24 PEGASYSTEMS INC.: REGIONAL REVENUE

FIGURE 25 SIEMENS HEALTHCARE: KEY FINANCIALS

FIGURE 26 SIEMENS HEALTHCARE: SEGMENTAL REVENUE

FIGURE 27 SIEMENS HEALTHCARE: REGIONAL REVENUE

FIGURE 28 KONINKLIJKE PHILIPS N.V.: KEY FINANCIALS

FIGURE 29 KONINKLIJKE PHILIPS N.V.: SEGMENTAL REVENUE

FIGURE 30 KONINKLIJKE PHILIPS N.V.: REGIONAL REVENUE

FIGURE 31 EXL HEALTHCARE: KEY FINANCIALS

FIGURE 32 EXL HEALTHCARE: SEGMENTAL REVENUE

FIGURE 33 EXL HEALTHCARE: REGIONAL REVENUE

FIGURE 34 HARMONY INFORMATION SYSTEMS, INC.: KEY FINANCIALS

FIGURE 35 HARMONY INFORMATION SYSTEMS, INC.: SEGMENTAL REVENUE

FIGURE 36 HARMONY INFORMATION SYSTEMS, INC.: REGIONAL REVENUE

FIGURE 37 SCIENCESOFT USA CORPORATION.: KEY FINANCIALS

FIGURE 38 SCIENCESOFT USA CORPORATION.: SEGMENTAL REVENUE

FIGURE 39 SCIENCESOFT USA CORPORATION.: REGIONAL REVENUE

Chronic Disease Management Market